{"id":"W2340806160","doi":"10.1136/rmdopen-2015-000210","title":"Reductions in disease activity in the AMPLE trial: clinical response by baseline disease duration","year":2016,"lang":"en","type":"article","venue":"RMD Open","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada; Sanofi; Amgen; Pfizer; Genentech; Celgene; AstraZeneca; Coherus Biosciences; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Adalimumab; Abatacept; Internal medicine; Rheumatoid arthritis; Methotrexate; Post-hoc analysis; Rheumatology; Clinical trial; Disease; Physical therapy; Rituximab","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003663084,0.0007534128,0.002218683,0.0002036898,0.0002081757,0.0006674904,0.0004791577,0.0008984065,0.005963649],"category_scores_gemma":[0.002808777,0.000257067,0.001292516,0.0002070041,0.0005694876,0.0009108855,0.000442998,0.001751106,0.0005611773],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002753781,"about_ca_system_score_gemma":0.0003416106,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001962377,"about_ca_topic_score_gemma":0.0005650115,"domain_scores_codex":[0.9982265,0.001309566,0.00008284004,0.000155994,0.000108505,0.0001166442],"domain_scores_gemma":[0.9977911,0.0008215733,0.000818513,0.0001517381,0.0001003339,0.0003167328],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9818674,0.001353527,0.003356513,0.0006568729,0.0007087955,0.00002515795,0.00003656109,0.0002550411,0.0009819468,0.00007622464,0.0006432832,0.01003858],"study_design_scores_gemma":[0.7823025,0.1775037,0.03218124,0.0003435363,0.001908296,0.000226822,0.00007756431,0.0006595406,0.0006285748,0.0003701384,0.003754944,0.00004306622],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9819613,0.01199811,0.0003993703,0.0006614418,0.0001789609,0.0008964631,0.001469384,0.00003958196,0.00239555],"genre_scores_gemma":[0.9891568,0.002476344,0.0007128305,0.0005187396,0.0004194931,0.002240002,0.00168024,0.00001641882,0.002778956],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005963649,"threshold_uncertainty_score":0.01995039,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07824353202588688,"score_gpt":0.4242618937616006,"score_spread":0.3460183617357138,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}